Monkeypox Epidemic Update: Global Trends and Public Health Concerns
The global monkeypox outbreak, which began in May 2022, continues to evolve with significant challenges in Africa and ongoing transmission in other parts of the world. As of September 2025, the outbreak has spread to 122 countries, with sustained human-to-human transmission documented in several nations, including the Central African Republic and the Republic of the Congo[2].
Current Situation
- Global Spread: The monkeypox virus, now commonly referred to as mpox, has resulted in more than 100,000 cases globally, with infections reported in 122 countries. This includes 115 countries where the disease was not previously endemic[2].
- Africa’s Growing Crisis: In Africa, particularly in the Democratic Republic of the Congo, Sierra Leone, and Malawi, the disease has surged, leading to over 139,000 suspected cases and nearly 1,800 deaths between January 2024 and May 2025[4]. The new clade Ia variant, with mutations like APOBEC3, raises concerns about increased transmissibility and adaptability[4].
- Outside Africa: Clade IIb, primarily affecting men who have sex with men, remains prevalent in non-African countries but at a lower level than during the initial outbreak in 2022-2023[3][6].
Public Health Response
- Vaccination Efforts: The U.S. government has provided significant support, including donating vaccine doses to affected countries like the Democratic Republic of the Congo[5].
- WHO Declaration: On August 14, 2024, the World Health Organization (WHO) declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC), emphasizing the need for global coordination[1][3].
What This Means for Public Health
This ongoing outbreak highlights the need for continued vigilance and proactive measures to control the spread of mpox. The evolving nature of the virus, particularly with new variants, underscores the importance of monitoring and adapting public health strategies. For those traveling to affected regions, staying informed about local health advisories and considering vaccination if eligible is crucial.
Expert Commentary
Public health experts emphasize that the shift in transmission patterns, from primarily sexual networks to broader community spread in Africa, necessitates a comprehensive approach to prevention and vaccination. The fact that mpox can affect a wide range of individuals, including children and healthcare workers, further complicates control efforts.
Next Steps in Research and Response
Future research should focus on understanding the genetic mutations of new variants and their impact on transmission and disease severity. Additionally, expanding access to vaccines and ensuring equitable distribution will be crucial in controlling the spread globally. The international community’s response, including financial and technical support, is vital to mitigate this public health crisis.
In conclusion, the mpox epidemic continues to challenge global health systems, requiring sustained effort and collaboration to combat its spread and mitigate its impact on vulnerable populations.
